Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Cytidine | HCID 6175 | — |
| Reactant | Palmitic anhydride | HCID 69339 | — |
| Reactant | Sapacitabine | HCID 153970 | — |
| Solvent | Dimethylformamide | HCID 6228 | — |
| Product | N-Hexadecanoylcytidine | HCID 22879539 | — |
Reaction Steps
The preparation of CYC682 described in EP 536936 (see Scheme 1 below) involves reacting cytidine [1] with palmitic anhydride in DMF to form N4-palmitoylcytidine [2] and subsequently protecting with 1,3-dichloro-1,1,4,4-tetraisopropyldisiloxane (CIPS) to form intermediate [3]. Oxidation of [3] with pyridinium dichromate/acetic anhydride in dichloromethane produces intermediate ketone [4], which is then reacted with sodium cyanide and sodium dihydrogen phosphate dihydrate in ethyl acetate to form the cyanohydrin [5]. Intermediate [5] is then reacted with N,N-dimethylaminopyridine, phenoxythiocarbonyl chloride and triethylamine to form intermediate [6], which is subsequently reacted with AIBN and tributyltin hydride in toluene to give intermediate [7]. Deprotection of [7] with acetic acid and tetrabutylammonium fluoride in THF yields the desired product, CYC682.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08884001B2 |
|---|
| Source dataset | uspto-grants-2014_11 |
|---|
| ORD ID | ord-bd91e273fcae44968a3f4283f4c7f41c |
|---|
| Source note | uspto-grants-2014_11 |
|---|